Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia. Clin Pharmacol Ther. 2008 Dec; 84(6):691-7.

View in: PubMed

subject areas

Antineoplastic Agents, Phytogenic
Case-Control Studies
Child
Child, Preschool
Drug Hypersensitivity
Etoposide
Female
Humans
Leukemia, Myeloid, Acute
Male
Myeloid-Lymphoid Leukemia Protein
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Predictive Value of Tests
Reference Values
Risk Assessment

authors with profiles

Mary Eileen Dolan